Thermo Fisher Scientific Introduces the DXR3 Family of Raman Spectroscopy Products

HILLSBORO, Ore., Sept. 25, 2019 /PRNewswire/ — Thermo Fisher Scientific today unveiled the next-generation Thermo Scientific DXR3 Family of Raman Spectrometers and Microscopes. This new generation features advanced imaging and work-flow capabilities to provide users with Raman analysis at the speed they need. Advanced particle analysis and 3D confocal visualization software delivers answers faster while the automatic x-axis calibration eliminates time-consuming manual calibration. Additionally, the DXR3 family is more flexible with an expanded offering of lasers and detectors. The DXR3 family includes the Thermo Scientific™ DXR3xi™ Raman Imaging Microscope, the Thermo Scientific™ DXR3™ Raman Microscope and the Thermo Scientific™ DXR3™ SmartRaman Spectrometer.

 

 

Designed to meet the demands of busy laboratories, the DXR3 Family of Raman products accelerates productivity in a broad range of industries, whether in QA/QC or fundamental research. Pharmaceutical drug developers will benefit from the DXR3xi’s advanced particle analysis and 3D visualization software in addition to its high-spatial resolution imaging system. Multi-purpose pharmaceutical labs can move from sample to answer faster by eliminating manual calibration steps with the automatic x-axis calibration. Polymer compounders can now visualize their confocal Raman data in three dimensions to help analyze failures and spot defects deep inside a material during product and process development. Environmental science researchers and food and beverage QA/QC analysts can more easily locate, count, and identify microplastics on filters, analyzing thousands of particles less than 10um in size in one highly automated workflow.

“The DXR3 Family of Raman products furthers Thermo Fisher Scientific’s global leadership in Raman spectroscopy with improved performance and next-generation software tools that make high-performance chemical information quickly accessible to all,” said Denzil Vaughn, senior business director of vibrational spectroscopy at Thermo Fisher Scientific. “The DXR3 Family maximizes the power of Raman spectroscopy with enhanced software, improved reliability, and a broader range of hardware options. These enhance the speed of material analysis and make it easier for Raman users across all markets to capture meaningful information that furthers their research.”

The DXR3 Family expands on the previous family of Raman products, continuing to offer modern spectrograph performance, continuous laser power control, and global service and support. These products are designed to work with a broad portfolio of complementary spectroscopy and analytical instruments offered by Thermo Fisher Scientific.

For more information on the DXR3 Family of Raman Spectrometers, please visit www.thermofisher.com/raman.

 

 

About Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit thermofisher.com.

Media Contact Information:
Kathy Gill
Thermo Fisher Scientific
+1 971-294-9262
kathy.gill@thermofisher.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-introduces-the-dxr3-family-of-raman-spectroscopy-products-300924907.html

SOURCE Thermo Fisher Scientific

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago